Online citations, reference lists, and bibliographies.
← Back to Search

Stereotactic Ablative Radiation Therapy For The Comprehensive Treatment Of Oligometastatic Tumors (SABR-COMET): Results Of A Randomized Trial

D. Palma, R. Olson, S. Harrow, S. Gaede, A. Louie, C. Haasbeek, L. Mulroy, M. Lock, G. Rodrigues, B. Yaremko, D. Schellenberg, B. Ahmad, G. Griffioen, S. Senthi, M. Liu, K. Moore, S. Currie, G. Bauman, A. Warner, S. Senan
Published 2018 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share



This paper is referenced by
10.1136/bmjopen-2019-035959
[18F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial
R. Glicksman (2020)
10.21873/anticanres.13066
Outcomes After Radiotherapy Alone for Metastatic Spinal Cord Compression in Patients with Oligo-metastatic Breast Cancer
D. Rades (2018)
10.1038/s41598-020-64770-2
Clinical efficacy of Stereotactic Body Radiation Therapy (SBRT) for adrenal gland metastases: A multi-center retrospective study from China
X. Zhao (2020)
10.2217/fon-2018-0923
Local therapy combined with chemotherapy versus chemotherapy for postoperative oligometastatic non-small-cell lung cancer.
Shuheng Shang (2019)
10.1016/J.CLLC.2019.05.015
Predictors of Respiratory Decline Following Stereotactic Ablative Radiotherapy to Multiple Lung Tumors.
Everett J. Moding (2019)
10.21037/JTD.2019.08.17
Correspondence to the editorials on "Comparison of stereotactic body radiotherapy versus metastasectomy outcomes in patients with pulmonary metastases".
Hojin Jeong (2019)
10.1186/s12885-019-6449-8
Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer
M. Kissel (2019)
10.1016/j.canrad.2019.01.002
Stereotactic radiotherapy in targeted therapy treated oligo-metastatic oncogene-addicted (non-small-cell) lung cancer.
N. Giraud (2019)
10.1016/j.ijrobp.2020.02.468
Curing Metastatic Disease With Ablative Radiation Therapy: Separating Truth From Wish.
S. C. Kamran (2020)
10.1016/j.clon.2019.05.015
The Dandelion Dilemma Revisited for Oligoprogression: Treat the Whole Lawn or Weed Selectively?
P. H. Patel (2019)
10.1200/JCO.19.00201
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.
D. Gomez (2019)
10.1016/j.ijrobp.2019.06.2466
Temporal trends of resident experience in external beam radiation therapy cases: analysis of ACGME case logs from 2007-2018.
R. Li (2019)
10.1016/j.rpor.2019.12.019
Radiation therapy for bone-only metastases in breast cancer patients: A GOCO survey of current clinical practice.
M. Bonet (2020)
10.1038/s41598-020-68160-6
Development and validation of a nomogram prognostic model for esophageal cancer patients with oligometastases
B. Li (2020)
10.12968/hmed.2019.80.5.C70
Cancers of unknown primary.
J. Tay (2019)
CADTH RAPID RESPONSE REPORT: SUMMARY WITH CRITICAL APPRAISAL Homelike Models in Long Term Care: A Review of Clinical Effectiveness, Cost- Effectiveness, and Guidelines
Chantelle C. Lachance (2019)
10.3779/j.issn.1009-3419.2020.101.29
[Treatment for Brain Metastases from EGFR Mutations NSCLC Patients:
 How Should We Choose in Clinical Practice?]
C. Cheng (2020)
10.6004/jnccn.2018.7112
Metastatic Anal Carcinoma: The Role of Radiotherapy.
Y. Chen (2019)
10.1016/j.ijrobp.2019.06.2431
Correlation of Dosimetric Factors with Development of Symptomatic Radiation Pneumonitis in Stereotactic Body Radiotherapy
Jeffrey M Ryckman (2019)
10.1016/j.ijrobp.2019.05.066
Comparison of Stereotactic Body Radiotherapy and Transarterial Chemoembolization for Unresectable Medium-sized Hepatocellular Carcinoma.
Po-Chien Shen (2019)
10.1016/j.ctrv.2019.01.005
Oligometastatic prostate cancer: The game is afoot.
A. Lancia (2019)
10.1016/j.crad.2019.05.003
New concepts in prostate cancer management: the conundrum of managing oligometastatic disease in prostate cancer-through the looking glass darkly.
V. Khoo (2019)
10.21873/anticanres.14321
The Role of Radiotherapy for Patients With Thyroid Cancer in the Modern Era
Laith Samhouri (2020)
10.3171/2019.12.SPINE191269
Spine stereotactic radiosurgery for metastatic thyroid cancer: a single-institution experience.
David Boyce-Fappiano (2020)
10.1007/s11060-019-03149-4
Natural history, clinical course and predictors of interval time from initial diagnosis to development of subsequent NSCLC brain metastases
D. R. Smith (2019)
10.1055/a-0883-6583
[Stereotactic Body Radiation Therapy for Liver Metastases].
D. Krug (2019)
10.1016/j.prro.2019.02.013
NRG Oncology/RTOG 0438: A Phase 1 Trial of Highly Conformal Radiation Therapy for Liver Metastases.
L. Dawson (2019)
10.1016/j.jvir.2020.02.016
Predictors of Progression-Free Survival and Local Tumor Control after Percutaneous Thermal Ablation of Oligometastatic Breast Cancer: Retrospective Study.
F. Ridouani (2020)
10.1007/978-3-030-48767-6
Image-Guided Interventions in Oncology: An Interdisciplinary Approach
Christos S Georgiades (2020)
About metachronous oligometastatic cancer
(2020)
10.1016/J.HOC.2019.08.017
Radiation Therapy for Prostate Cancer.
S. C. Kamran (2020)
10.1186/s13014-020-01559-7
Intraoperative radiotherapy with low energy x-rays for primary and recurrent soft-tissue sarcomas
G. R. Sarria (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar